The University of Chicago Header Logo

Amelia Kellar

Concepts (70)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Crohn Disease
13
2026
808
3.430
Why?
Colitis, Ulcerative
6
2025
800
2.110
Why?
Inflammatory Bowel Diseases
7
2025
646
1.950
Why?
Ultrasonography
10
2026
702
1.530
Why?
Intestines
5
2026
432
1.260
Why?
Remission Induction
5
2025
738
1.200
Why?
Mesentery
2
2026
46
1.180
Why?
Adipose Tissue
2
2026
270
0.990
Why?
Gastroenterologists
1
2022
31
0.730
Why?
Fat Necrosis
1
2017
6
0.540
Why?
Panniculitis
1
2017
11
0.530
Why?
Subcutaneous Fat
1
2017
21
0.530
Why?
Decision Support Techniques
1
2019
185
0.530
Why?
Hypocalcemia
1
2017
43
0.530
Why?
Child
8
2026
7355
0.520
Why?
Point-of-Care Systems
2
2026
150
0.400
Why?
Gastrointestinal Agents
2
2025
181
0.380
Why?
Adolescent
7
2026
9606
0.360
Why?
Severity of Illness Index
5
2026
1917
0.350
Why?
Colon
2
2026
540
0.300
Why?
Colonoscopy
2
2023
303
0.290
Why?
Disease Models, Animal
1
2015
2495
0.270
Why?
Retrospective Studies
6
2025
10164
0.270
Why?
Humans
18
2026
93511
0.260
Why?
Female
12
2026
48698
0.250
Why?
Ileum
3
2024
167
0.240
Why?
Male
11
2026
44553
0.240
Why?
Heterocyclic Compounds, 3-Ring
1
2024
42
0.210
Why?
Reference Values
1
2025
608
0.210
Why?
Reproducibility of Results
2
2026
2715
0.190
Why?
Lung Neoplasms
1
2015
2365
0.190
Why?
Drug Therapy, Combination
1
2024
759
0.180
Why?
Biological Products
1
2024
178
0.170
Why?
Anorexia
1
2021
26
0.170
Why?
Feces
1
2022
360
0.160
Why?
Consensus
1
2022
368
0.160
Why?
Exanthema
1
2021
39
0.160
Why?
Young Adult
4
2026
6930
0.160
Why?
Biomarkers
1
2026
1910
0.150
Why?
Predictive Value of Tests
2
2024
1713
0.150
Why?
Endoscopy, Gastrointestinal
1
2019
160
0.140
Why?
Treatment Outcome
3
2025
9098
0.130
Why?
Adalimumab
1
2017
92
0.130
Why?
Clinical Trials as Topic
2
2023
1103
0.110
Why?
Databases, Factual
1
2019
1006
0.110
Why?
Postoperative Complications
1
2026
2562
0.110
Why?
Skin
1
2017
578
0.100
Why?
Infant, Newborn
1
2017
2479
0.090
Why?
Cross-Sectional Studies
2
2026
1847
0.070
Why?
ROC Curve
2
2023
775
0.070
Why?
Postoperative Period
1
2026
315
0.060
Why?
Anastomosis, Surgical
1
2026
280
0.050
Why?
Infliximab
1
2025
162
0.050
Why?
Janus Kinase Inhibitors
1
2024
29
0.050
Why?
Antineoplastic Agents
1
2015
2303
0.050
Why?
Biological Therapy
1
2024
46
0.050
Why?
C-Reactive Protein
1
2024
204
0.050
Why?
Recurrence
1
2026
1190
0.050
Why?
Prospective Studies
2
2024
4560
0.050
Why?
Pregnancy Complications
1
2025
352
0.050
Why?
Mice
1
2015
12269
0.040
Why?
Longitudinal Studies
1
2024
1161
0.040
Why?
Motor Skills
1
2021
77
0.040
Why?
Adult
3
2026
27918
0.040
Why?
Sensitivity and Specificity
1
2023
1922
0.040
Why?
Pregnancy
1
2025
3147
0.030
Why?
Animals
1
2015
28155
0.030
Why?
Infant
1
2021
3220
0.030
Why?
Logistic Models
1
2017
1243
0.030
Why?
Middle Aged
2
2026
27569
0.020
Why?
Kellar's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (70)
Explore
_
Co-Authors (2)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_